Assertion: liposome's drug | /r/CapableOf | remain inaccessible
Facets:
value: at an affordable price in kenya
type: MANNER
value: largely
type: DEGREE
Source sentences:
text: The MSF said that the problem has been caused by a monopoly by Gilead Sciences, a pharmaceutical firm that has failed to deliver on promises to make the drug available to people suffering from HIV.Last year, Gilead announced its 'access initiative' promising lower prices for liposomal amphotericin B (L-AMB) in 116 developing countries, Kenya included but to date, the drug largely remains inaccessible and unavailable at an affordable price in Kenya.